Food Response Training for Binge Eating

Status Terminated

Clinical Trial Summary

This study will examine the effectiveness of food response training interventions in reducing binge eating among adults engaged in binge eating.

Clinical Trial Description

Binge eating disorder is the most prevalent eating disorder and affects both men and women at comparable rates unlike anorexia nervosa and bulimia nervosa. Given that binge eating and obesity are strongly associated, binge eating treatments should aim to reduce binge eating as well as weight. However, most binge eating interventions do not produce lasting weight loss. Recent research has shown computer-based response inhibition training with high-calorie foods reduces reward region response to and attentional bias for the training foods, decreases training food intake, increases inhibitory control, and produces weight loss in overweight adults. There is evidence that the weight loss effects from such response training persist through 6-month follow-up. Further, binge eating has been associated with increased food-related impulsivity and increased activation in a reward-processing brain region to high-calorie foods. Prior research suggests that food response training may be an effective intervention for binge eating that teaches automatic self-control in response to high-calorie foods which in turn, reduces binge eating and produces weight loss. This study will examine the effectiveness of food response training interventions in reducing binge eating and weight among adults engaged in binge eating.

The goals of this study are to: (1) test the hypothesis that adults who complete the food response trainings will show significantly greater reductions in binge eating frequency and in body mass index (BMI) compared to generic response training from pretest to posttest and at 3-month follow up, (2) to determine whether one of the food response trainings is more effective in binge eating frequency and reducing BMI from pretest to posttest and at 3-month follow up, and (3) test whether a reduction in valuation of the high-calorie versus low-calorie foods (willingness to pay for the pictured foods) and/or behavioral improvement of inhibitory control during the training tasks mediate the effects of the various trainings on reductions in binge frequency and body mass index. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02817412
Study type	Interventional
Source	Loma Linda University
Contact
Status	Terminated
Phase	N/A
Start date	June 2016
Completion date	April 24, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04038190` - A Behavioral Activation Intervention Administered in a College Freshman Orientation Course	Phase 2
Terminated	`NCT04278755` - Binge Eating & Birth Control	Phase 2
Not yet recruiting	`NCT06454123` - Feasibility of a Digital Therapeutic for Adults With Binge Eating and Obesity	N/A
Completed	`NCT00537810` - Treatment of Binge Eating in Obese Patients in Primary Care	Phase 4
Recruiting	`NCT05509257` - Naltrexone Neuroimaging in Teens With Eating Disorders	Early Phase 1
Completed	`NCT03687658` - Applying Novel Technologies and Methods to Self-Regulation: Behavior Change Tools for Smoking and Binge Eating	N/A
Not yet recruiting	`NCT06326099` - Brief Binge Eating and Drinking Online Intervention	N/A
Recruiting	`NCT05937243` - Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating	N/A
Completed	`NCT00607789` - Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression	Phase 4
Completed	`NCT04117542` - Working Memory in Overweight Children With and Without Loss of Control Eating
Recruiting	`NCT04211818` - Analysis of the Glycemic Profile of People Suffering From Compulsive Eating Disorders Aiming to Offer an Innovative Nutritional Approach (GLUCOPULSE)	N/A
Completed	`NCT03429114` - Emotion Regulation in Binge Eating and Purging Among Adolescents
Completed	`NCT05041660` - Using Virtual Reality and Sensor Technology to Enhance Outcomes From Treatment for Binge Eating	N/A
Completed	`NCT03007459` - The Health of Competitive Fitness Athletes
Completed	`NCT02180984` - The Effects of Repetitive Transcranial Magnetic Stimulation in Obese People With BED	N/A
Completed	`NCT00829283` - Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care	N/A
Completed	`NCT00307619` - An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.	Phase 3
Active, not recruiting	`NCT04127214` - The ITA Model of Integrated Treatment of Eating Disorders
Not yet recruiting	`NCT06129461` - A Single Session Self-guided Acceptance-based Digital Intervention Targeting Food Cravings in Pregnancy	N/A
Recruiting	`NCT05177705` - The Intersection Between Loss of Control Eating and Obesity: The Role of Restriction and Food Reinforcement	Early Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.